Status:
COMPLETED
Therapeutic Education Program in Psoriasis
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Psoriasis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this research protocol is to assess the effect of a structured therapeutic education program on the quality of life of patients with moderate to severe psoriasis
Detailed Description
Psoriasis is a chronic inflammatory skin disease affecting 1 to 3% of the French population. Moderate to severe psoriasis has a significant impact on quality of life. Psoriasis is associated with an i...
Eligibility Criteria
Inclusion
- Moderate to severe psoriasis defined as patients receiving a systemic psoriasis treatment including methotrexate, cyclosporine, PUVA, retinoids or a biological agent and with significant impact on quality of life defined as a Skindex \> 18
- Patients with palmo-plantar or erythrodermic psoriasis may be included if they can be classified as moderate to severe according the above described definitions
Exclusion
- Patients not able to give informed consent,
- Patients not able to follow the program,
- Patients without social security affiliation.
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
187 Patients enrolled
Trial Details
Trial ID
NCT02310204
Start Date
May 1 2011
End Date
June 1 2014
Last Update
February 2 2022
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Brest, France, 29609
2
Edouard Herriot
Lyon, France, 69437
3
Unversity Hospital
Lyon, France, 69437
4
Timone Hospital
Marseille, France, 13000